drugset / Trial / NCT02291549
S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps
RandomizedParallel-groupDouble-blindTreatment
Summary
The RESOLVE II Study is a randomized, single-blind, parallel arm, concurrently controlled, multicenter study with 300 chronic sinusitis patients who had prior endoscopic sinus surgery but present with recurrent sinus obstruction.
Timeline
- Start
- 2014-12
- Primary completion
- 2016-10
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Mometasone furoate | Other / unclassified | 1350 ug | Other |
| Background | Mometasone furoate | Other / unclassified | 200 ug | Intranasal |